184 related articles for article (PubMed ID: 36715361)
1. Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection.
Knuutila A; Dalby T; Ahvenainen N; Barkoff AM; Jørgensen CS; Fuursted K; Mertsola J; He Q
Emerg Microbes Infect; 2023 Dec; 12(1):e2174782. PubMed ID: 36715361
[TBL] [Abstract][Full Text] [Related]
2. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies.
Abu-Raya B; Giles ML; Kollmann TR; Sadarangani M
Front Immunol; 2019; 10():2423. PubMed ID: 31681310
[No Abstract] [Full Text] [Related]
4. Age-related differences in antibody avidities to pertussis toxin and filamentous hemagglutinin in a healthy Japanese population.
Fumimoto R; Otsuka N; Sunagawa T; Tanaka-Taya K; Kamiya H; Kamachi K
Vaccine; 2019 Apr; 37(18):2463-2469. PubMed ID: 30930008
[TBL] [Abstract][Full Text] [Related]
5. Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccination.
Prelog M; Almanzar G; Rieber N; Ottensmeier B; Zlamy M; Liese J
Vaccine; 2013 Jan; 31(2):387-93. PubMed ID: 23142306
[TBL] [Abstract][Full Text] [Related]
6. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.
Dalby T; Petersen JW; Harboe ZB; Krogfelt KA
J Med Microbiol; 2010 Sep; 59(Pt 9):1029-1036. PubMed ID: 20508003
[TBL] [Abstract][Full Text] [Related]
7. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
[TBL] [Abstract][Full Text] [Related]
8. Assessment of IgG avidity against pertussis toxin and filamentous hemagglutinin via an adapted enzyme-linked immunosorbent assay (ELISA) using ammonium thiocyanate.
Almanzar G; Ottensmeier B; Liese J; Prelog M
J Immunol Methods; 2013 Jan; 387(1-2):36-42. PubMed ID: 23022630
[TBL] [Abstract][Full Text] [Related]
9. Assessment of IgA anti-PT and IgG anti-ACT reflex testing to improve Bordetella pertussis serodiagnosis in recently vaccinated subjects.
Subissi L; Rodeghiero C; Martini H; Litzroth A; Huygen K; Leroux-Roels G; Piérard D; Desombere I
Clin Microbiol Infect; 2020 May; 26(5):645.e1-645.e8. PubMed ID: 31610300
[TBL] [Abstract][Full Text] [Related]
10. Anti-pertussis antibody kinetics following DTaP-IPV booster vaccination in Norwegian children 7-8 years of age.
Aase A; Herstad TK; Jørgensen SB; Leegaard TM; Berbers G; Steinbakk M; Aaberge I
Vaccine; 2014 Oct; 32(45):5931-6. PubMed ID: 25218299
[TBL] [Abstract][Full Text] [Related]
11. Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay.
Fry NK; Litt DJ; Duncan J; Vaghji L; Warrener L; Samuel D; Andrews N; Harnden A; Harrison TG
J Med Microbiol; 2013 Sep; 62(Pt 9):1281-1289. PubMed ID: 23722435
[TBL] [Abstract][Full Text] [Related]
12. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
[TBL] [Abstract][Full Text] [Related]
13. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis.
Taranger J; Trollfors B; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
J Infect Dis; 2000 Mar; 181(3):1010-3. PubMed ID: 10720524
[TBL] [Abstract][Full Text] [Related]
14. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.
Hendrikx LH; Berbers GA; Veenhoven RH; Sanders EA; Buisman AM
Vaccine; 2009 Nov; 27(47):6530-6. PubMed ID: 19729085
[TBL] [Abstract][Full Text] [Related]
15. Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium.
Caboré RN; Maertens K; Dobly A; Leuridan E; Van Damme P; Huygen K
Virulence; 2017 Oct; 8(7):1245-1254. PubMed ID: 28277900
[TBL] [Abstract][Full Text] [Related]
16. A General Lack of IgG Against Pertussis Toxin in Chinese Pregnant Women and Newborns.
Meng QH; Luo J; Yang F; Shen YJ; Li L; Li LJ; Shi W; Wang YJ; Yao KH
Pediatr Infect Dis J; 2018 Sep; 37(9):934-938. PubMed ID: 29406469
[TBL] [Abstract][Full Text] [Related]
17. Pertussis toxin neutralizing antibody response after an acellular booster vaccination in Dutch and Finnish participants of different age groups.
Knuutila A; Versteegen P; Barkoff AM; van Gageldonk P; Mertsola J; Berbers G; He Q;
Emerg Microbes Infect; 2022 Dec; 11(1):956-963. PubMed ID: 35286231
[No Abstract] [Full Text] [Related]
18. Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children.
Sato Y; Sato H
Dev Biol Stand; 1985; 61():367-72. PubMed ID: 3835079
[TBL] [Abstract][Full Text] [Related]
19. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
[TBL] [Abstract][Full Text] [Related]
20. Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children.
von Linstow ML; Pontoppidan PL; von König CH; Cherry JD; Hogh B
Eur J Pediatr; 2010 Sep; 169(9):1119-22. PubMed ID: 20373111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
